Description
Leukaemic stem cells in AML: where are we now? An update on recent findings and detection
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: Leukaemic stem cells in AML: where are we now? An update on recent findings and detection
€3.03
Reviews
There are no reviews yet.